Navigation Links
Epizyme, Inc. to Present Pre-Clinical Data on DOT1L and EZH2 Inhibitor Programs at the 55th ASH Annual Meeting
Date:11/7/2013

CAMBRIDGE, Mass., Nov. 7, 2013 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, will present pre-clinical data on EPZ-5676 and EPZ-6438, the Company's DOT1L and EZH2 clinical programs, at the 55th Annual Meeting of the American Society of Hematology (ASH) in New Orleans on December 7-10, 2013.

"EPZ-5676, our DOT1L inhibitor, and EPZ-6438, our EZH2 inhibitor, are currently being developed as single-agent treatments based on the durable tumor regressions seen in pre-clinical studies," said Robert A. Copeland, Ph.D., executive vice president and chief scientific officer, Epizyme. "Two of our ASH presentations highlight the synergistic efficacy we have demonstrated in pre-clinical combination studies with each of our clinical candidates in specific genetically defined tumors. These data point us towards the potential use of our therapeutic candidates in combination treatment settings. Additionally, we are pleased to present data at ASH highlighting the opportunity to pursue a second genetically defined cancer, MLL-PTD, with EPZ-5676. MLL-PTD represents a distinct genetically defined acute leukemia in addition to our current clinical focus on MLL-r."

EPZ-5676, an inhibitor of the histone methyltransferase (HMT) DOT1L, is being developed as a treatment for patients with acute leukemias with rearrangements of the MLL gene (MLL-r). In the fourth quarter of 2013, Epizyme plans to announce top-line dose escalation data from the ongoing Phase 1 clinical study and, based on this data, initiate an expansion cohort stage that will be limited to patients with MLL-r.

EPZ-6438 is an inhibitor of the HMT EZH2 being developed as a tr
'/>"/>

SOURCE Epizyme, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Epizyme, Inc. Files Registration Statement for Proposed Initial Public Offering
2. Epizyme, Inc. Announces Pricing of Initial Public Offering
3. Epizyme, Inc. to Webcast Conference Call Discussing Second Quarter 2013 Financial Results on July 31, 2013
4. Epizyme, Inc. to Present at Wedbush Securities Life Sciences Management Access Conference in August
5. Epizyme, Inc. to Present at Upcoming Conferences in September
6. Epizyme, Inc. Granted Notice of Allowance of Patent for EPZ-5676
7. Epizyme, Inc. to Present at Upcoming Conferences in November
8. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
9. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
10. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 On Thursday, July ... the Dow Jones Industrial Average finished the day 0.42% lower ... 0.41%. The losses were broad based as eight out of ... Health Care Sector Index ended the day at 711.88, down ... one month. Investor-Edge has initiated coverage on the following equities: ...
(Date:7/11/2014)... 11, 2014  Veran Medical Technologies, a ... the positive, cost-effective final results for the ... The SPiNPerc endobronchial percutaneous biopsy study results ... to biopsy when a traditional bronchoscopic method ... experience positive financial outcomes when more can ...
(Date:7/10/2014)... , July 11, 2014  Major advances ... of cancer are being highlighted in a three-day ... from 10-12 July, 2014.  Renowned national and ... share best practices and exchange knowledge on modern ... accurate and efficient. The Summit ...
Breaking Medicine Technology:Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4Veran Medical Publishes Lung Cancer Patient Management Study 2Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
... China, May 3, 2012 /PRNewswire-Asia/ -- Winner Medical Group ... the "Company"), a leading China-based exporter and retailer of ... cotton, announced today that it will release financial results ... Winner Medical,s senior management will host a conference call ...
... 2012  Omeros Corporation (NASDAQ: OMER ) today ... with each of four additional orphan G protein-coupled receptors ... developing drugs targeting those receptors is extremely difficult. Omeros ... percent of the Class A orphan GPCRs. There are ...
Cached Medicine Technology:Winner Medical Group Inc. to Host Second Quarter 2012 Earning Conference Call on Thursday, May 10, 2012 at 9:00 p.m. EDT 2Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio 2Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio 3Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio 4
(Date:7/12/2014)... July 12, 2014 Demand Response Management ... considerable benefits in reducing the imbalance between energy supply ... appliances have been rolled out (due to increasing pressure ... (AMI). This helps in controlling residential appliances and thermostats ... in the North American region, and with government mandates ...
(Date:7/12/2014)... York, New York (PRWEB) July 12, 2014 ... liver damage allegations continue to move forward in ... Court, Eastern District of Pennsylvania, Bernstein Liebhard LLP ... 2014, U.S. District Judge Lawrence F. Stengel has ... Among other things, Judge Stengel found that the ...
(Date:7/12/2014)... 2014 (HealthDay News) -- Burn injuries increase in the summer ... say burn experts. Among those most vulnerable to these seasonal ... vulnerable and often get burned by putting their hands on ... of the burn unit at Loyola University Medical Center in ... old adage of ,When you play with fire, you get ...
(Date:7/12/2014)... “After my mom’s stroke, she loss the use of her ... use of his left side. Eating became a difficult task for ... like them enjoy eating again,” said an inventor, from Fayetteville, N.C. ... HALL PLATE (P C H PLATE). , The PATRICIA CAROL HALL ... eat for individuals who suffer from stroke, experience tremors or loss ...
(Date:7/12/2014)... July 12, 2014 With prom shopping ... manufacturer and retailer, is ready to showcase its new ... new collection of evening dresses in its online shop. ... 67% off) for these elegant gowns. According to the ... end on July 26, 2014. , He says, ...
Breaking Medicine News(10 mins):Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 4Health News:Burn Injuries More Common in Summer 2Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2
... in India, Brazil, China and South Africa, scientists say nanotechnology ... could give developing nations new ways to diagnose and treat ... manipulate and manufacture things on a scale of 1 to ... a sheet of paper is about 100,000 nanometers thick. ...
... say researchers. Take heart, not many, at least in Australia, have ... 2 percent of the population has a lesion on their brain ... . Out of these very few will actually trigger off ... D'Souza, a neurologist at St. Vincent's Hospital Melbourne and team, who ...
... Joseph Pilates invented this popular form of exercise, Pilates ... is widely recommended for losing weight, reducing or eliminating ... question whether Pilates is any good, at least for ... ,Participants of Pilates are taught to strengthen a ...
... its pound// of flesh. ,According to Scottish experts from ... the country. Diabetes Type 2, known as maturity ... 20s, 30s,and even in teens, something that was never heard of ... lifestyle and oneself. Fast food cheaper and more ...
... with colorectal cancer who require the surgical removal ... experimental procedure may decrease the time they spend// ... both the benefits of laparoscopic surgery and open ... affiliates are currently recruiting patients for a clinical ...
... U.S. Marine Corps, 50-year-old Joseph Wollschlager Jr. felt invincible. Until ... led to the diagnosis of a life-threatening brain tumor. Survival ... a year. ,But Wollschlager is fighting all the ... the University of Michigan Comprehensive Cancer Center, Wollschlager is back ...
Cached Medicine News:Health News:India, China Trying to Fight Disease With Nanotechnology 2Health News:India, China Trying to Fight Disease With Nanotechnology 3Health News:Simple Act of Brushing Your Teeth can Trigger an Epileptic Fit, Say Experts 2Health News:Pilates-new Age Gimmick or More? 2Health News:Pilates-new Age Gimmick or More? 3Health News:Ticking Time Bomb of Scotland-diabetes 2Health News:New Surgical Technique Decreases Colorectal OR Time 2Health News:New Protocol Targets Aggressive Brain Cancer 2
Comes complete with its own case. A unique integrated design with no need for two separate bars., ,Optical surfaces are recessed for optimum protection. Extensive prism power 1,2,3,4,6,8,10,15,20...
Well established test for children but suitable for disabled people, those with learning difficulties or patients who do not share a common language with the examiner....
... System is designed to provide easy and accurate ... and are at high risk for conventional surgery. ... Carotid Stent System is 6F sheath/8F guide catheter ... ACCULINK utilizes rapid exchange (RX) technology so that ...
The New Vantage Plus. The PLUS gives you: ,P Premium intelligent optics ,L Lighter weight and brighter images ,U Unique wireless patented technology ,S Smaller and more compact size ...
Medicine Products: